Faltblatt Peritoneum.indd - Universitätsklinikum Regensburg

Faltblatt Peritoneum.indd - Universitätsklinikum Regensburg

Speakers
General Information/Organization
Dr. Dirk Arnold
Universitätsklinikum Halle
Prof. Dr. David L. Bartlett
University of Pittsburgh, UPMC Cancer Pavillion, USA
Prof. Dr. Dennis S. Chi
Memorial Sloan-Kettering Cancer Center, New York, USA
Dr. Marcello Deraco
Instuto Nazionali Tumori Milano, Italy
Dr. Jesus Esquivel
St. Agnes Hospital, Baltimore, USA
Prof. Dr. Alfredo Garofalo
National Cancer Center Regina Elena, Roma, Italy
Prof. Dr. Olivier Glehen
Centre Hospitalier et Univ. Lyon, Pierre Benite cedex, France
Dr. Santiago Gonzalez-Moreno
Centro Oncologico MD Anderson, Madrid, Spain
Dr. Philipp Harter
Dr. Horst-Schmidt-Kliniken GmbH, Wiesbaden
Prof. Dr. Markus M. Heiss
Krankenhaus Merheim, Köln
Prof. Dr. C. William Helm
University of Louisville, USA
Dr. Felix Hilpert
UK-SH, Campus Kiel
Prof. Dr. Joachim Jähne
Henriettenstiftung, Hannover
Prof. Dr. Alfred Königsrainer
Universitätsklinik für Allgemeine Viszeralund Transplantationschirurgie, Tübingen
Prof. Dr. Björn Lampe
Florence-Nightingale-Krankenhaus, Düsseldorf
Prof. Dr. Karl Heinz Link
Asklepios Paulinen Klinik, Wiesbaden
Prof. Dr. Haile Matheme
Uppsala University, Sweden
PD Dr. Markus Moehler
Universitätsklinikum Mainz
Dr. Aviram Nissan
Hadassah University Mount Scopus, Jerusalem, Israel
Prof. Dr. Olaf Ortmann
Caritas KH St. Josef, Regensburg
Prof. Dr. Pompiliu Piso
Universitätsklinikum Regensburg
Prof. Dr. Dr. h. c. Peter M. Schlag
Robert Rössle Klinik Charité Campus, Berlin
Prof. Dr. Hans J. Schlitt
Universitätsklinikum Regensburg
Dr. Oliver Zivanovic
Universitätsfrauenklinik Bonn
Scientific Leadership
Prof. Dr. P. Piso
Prof. Dr. H. J. Schlitt
Congress Venue
University Hospital of Regensburg
Minor Lecture Hall
Congress Secretary
Irmgard Scheruebl
University Hospital
Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany
Phone
+49 941 944 6837
Fax
+49 941 944 6838
e-mail
[email protected]
Internet http://www.uniklinikum-regensburg.de/
Registration fee: 150 € (both days)
110 € (friday)
75 € (saturday)
Bavarian evening: September 18, 2009, Dinner charges 45 €
4th
International Symposium
on Peritoneal Carcinomatosis
University of Regensburg
September 18-19, 2009
Regensburg, Germany
Payment via Bank account:
Klinikum Regensburg
Bank code
750 500 00
Account No.
780 010 500
IBAN-Nr.
DE52750500000780010500
Swift-Code
BYLADEM1RBG
Project No.
374 42 34 (please quote)
Hotel Accomodation
Tourist Office Regensburg, Altes Rathaus
Phone
+49(0)941 507 4410
Fax
+49(0)941 507 4419
e-mail
[email protected]
Internet www.regensburg.de
Fortbildungspunkte
BLAEK 20 Punkte
Guest Speakers:
DL Bartlett, Pittsburgh;
D Chi, New York;
M Deraco, Milano;
J Esquivel, Baltimore;
O Glehen, Lyon;
S Gonzalez-Moreno, Madrid;
W Helm, Louisville;
H Mahteme, Uppsala;
A Nissan, Jerusalem
Scientific Leadership:
P Piso, HJ Schlitt, Regensburg
Dear colleagues,
cytoreductive surgery combined with hyperthermic intraperitoneal and systemic chemotherapy
represents a valid strategy for selected patients.
A lot has been learned over the last years. We
managed to reduce perioperative morbidity and
mortality, and have achieved a consensus regarding different aspects of the treatment. This symposium will focused on many practical details, as
well as several aspects of preclinical and clinical
research, e.g. quality of life, imaging or molecular diagnosis.
More than in the years before, GYN malignomas
will be the main topic of this meeting.
Looking forward to meet you in Regensburg, we
remain with best regards
H. J. Schlitt
P. Piso
Under the patronage of
- CAO der Deutschen Gesellschaft für Viszeralchirurgie
- Tumorzentrum Regensburg
- AIO (Arbeitsgemeinschaft Internistische Onkologie
- AGO (Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-Ovar)
Main Sponsors:
ThermaSolutions
Covidien Deutschland GmbH
Fresenius Biotech GmbH
Sponsors:
Amgen GmbH
Baxter Deutschland GmbH
EFS
Kardialgut GmbH
Merck Pharma GmbH
MSD Sharp & Dohme GmbH
Nycomed Deutschland GmbH
RanD S.r.l.
Roche Phama AG
Karl Storz GmbH & Co. KG
Program
Program
Friday, 18.09.2009
15:30 – 16:00 08:30 – 09:00 Welcome ceremony
P. Piso
Opening lectures
Chairmen: HJ Schlitt, J Esquivel
09:00 – 09:30 Objective barriers to making cytoreductive
surgery and hyperthermic intraperitoneal
chemotherapy standard of care
J Esquivel
09:30 – 10:00 How to get CRS and HIPEC into the guidelines – the French success
O Glehen
10:00 – 10:30 Patients selection for peritoneal carcinomatosis arising from colorectal cancer
S Gonzalez-Moreno
Ovarian cancer II
Chairmen: J Jaehne, W Helm
16:00 – 16:30 Hyperthermic intraperitoneal chemotherapy for ovarian cancer
W Helm
16:30 – 16:45 Role of complete cytoreduction for
recurrent ovarian cancer
P Harter
16:45 – 17:00 Pelvic exenteration for recurrent ovarian
cancer
B Lampe
10:30 – 11:00 Gastric cancer
Chairmen: PM Schlag, A Garofalo
09:00 – 09:30 National guidelines of gastric cancer: how
do they comment on diagnosis and treatment of peritoneal carcinosis ?
M Moehler
09:30 – 10:00 Selection of patients with gastric cancer
and PC for CRS and HIPEC
O Glehen
10:00 – 10:15 German GASTRIPEC trial
PM Schlag
10:15 – 10:30 Adjuvant intraperitoneal immunotherapy
MM Heiss
Coffee Break and sponsor visiting
Colorectal cancer
Chairmen: KH Link, A Nissan
11:00 – 11:15 Guidelines for treatment of metastastic
colorectal cancer in Germany
D Arnold
11:15– 11:30 The German Phase II study on PC from colorectal cancer
P. Piso
11:30 – 11:45 Ideal study on multimodality approach for PC
A Nissan
11:45 – 12:30 Free papers
12:30 – 14:00 Lunch and sponsor visiting
Ovarian cancer I
Chairmen: P Piso, D Chi
14:00 – 14:30 German guidelines for treatment of primary
and/or recurrent ovarian cancer with peritoneal carcinomatosis
F Hilpert
14:30 – 14:50 Ovarian Team – a multidisciplinary approach
with advanced cytoreductive surgery
D Chi
14:50 – 15:00 GYN-Oncology training at the Memorial
Sloan Kettering – my lessons
O Zivanovic
15:00 – 15:30 What about intraperitoneal chemotherapy ?
Pro: D Chi / Con: O Ortmann
19:00
Coffee Break and sponsor visiting
Bavarian evening
Saturday, 19.09.2009
10:30 – 11:00 Coffee Break and sponsor visiting
Malignant peritoneal mesothelioma
Chairmen: A Koenigsrainer, DL Bartlett
11:00 – 11:30 CRS and HIPEC – UMPC data
DL Bartlett
11:30 – 12:00 CRS and HIPEC – Italian data
M Deraco
12:00 – 13:00 Free papers
13:00 – 13:30 Future perspectives and announcement of
the Uppsala meeting 2009
H Mahteme
following Lunch break
Call for Abstracts
[email protected]
Deadline: July, 1 2009